|
1
|
Shah BH, Nawaz Z, Pertani SA, Roomi A,
Mahmood H, Saeed SA and Gilani AH: Inhibitory effect of curcumin, a
food spice from turmeric, on platelet-activating factor- and
arachidonic acid-mediated platelet aggregation through inhibition
of thromboxane formation and Ca2+ signaling. Biochem
Pharmacol. 58:1167–1172. 1999.
|
|
2
|
Yuan HY, Kuang SY, Zheng X, et al:
Curcumin inhibits cellular cholesterol accumulation by regulating
SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle
cells. Acta Pharmacol Sin. 29:555–563. 2008.
|
|
3
|
Chen WF, Deng SL, Zhou B, Yang L and Liu
ZL: Curcumin and its analogues as potent inhibitors of low density
lipoprotein oxidation: H-atom abstraction from the phenolic groups
and possible involvement of the 4-hydroxy-3-methoxyphenyl groups.
Free Radic Biol Med. 40:526–535. 2006.
|
|
4
|
Chen H, Zhang ZS, Zhang YL and Zhou DY:
Curcumin inhibits cell proliferation by interfering with the cell
cycle and inducing apoptosis in colon carcinoma cells. Anticancer
Res. 19:3675–3680. 1999.
|
|
5
|
Kuo ML, Huang TS and Lin JK: Curcumin, an
antioxidant and anti-tumor promoter, induces apoptosis in human
leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996.
|
|
6
|
Mehta K, Pantazis P, McQueen T and
Aggarwal BB: Antiproliferative effect of curcumin
(diferuloylmethane) against human breast tumor cell lines.
Anticancer Drugs. 8:470–481. 1997.
|
|
7
|
Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen
P, Zhu BT, Newmark H and Ho CT: Effect of dietary curcumin and
dibenzoylmethane on formation of 7,12-dimethylbenz[a]
anthracene-induced mammary tumors and lymphomas/leukemias in Sencar
mice. Carcinogenesis. 19:1697–1700. 1998.
|
|
8
|
Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin
JK, Lai GM, Hsieh CY and Cheng AL: Curcumin-containing diet
inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.
Carcinogenesis. 21:331–335. 2000.
|
|
9
|
Kawamori T, Lubet R, Steele VE, Kelloff
GJ, Kaskey RB, Rao CV and Reddy BS: Chemopreventive effect of
curcumin, a naturally occurring anti-inflammatory agent, during the
promotion/progression stages of colon cancer. Cancer Res.
59:597–601. 1999.
|
|
10
|
Limtrakul P, Lipigorngoson S, Namwong O,
Apisariyakul A and Dunn FW: Inhibitory effect of dietary curcumin
on skin carcinogenesis in mice. Cancer Lett. 116:197–203. 1997.
|
|
11
|
Srivastava R, Dikshit M, Srimal RC and
Dhawan BN: Anti-thrombotic effect of curcumin. Thromb Res.
40:413–417. 1985.
|
|
12
|
Nirmala C and Puvanakrishnan R: Protective
role of curcumin against isoproterenol induced myocardial
infarction in rats. Mol Cell Biochem. 159:85–93. 1996.
|
|
13
|
Nishiyama T, Mae T, Kishida H, Tsukagawa
M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K
and Kitahara M: Curcuminoids and sesquiterpenoids in turmeric
(Curcuma longa L.) suppress an increase in blood glucose
level in type 2 diabetic KK-Ay mice. J Agric Food Chem. 53:959–963.
2005.
|
|
14
|
Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz
RC, Jolad SD, Sólyom AM and Timmermann BN: Turmeric extracts
containing curcuminoids prevent experimental rheumatoid arthritis.
J Nat Prod. 69:351–355. 2006.
|
|
15
|
Hong RL, Spohn WH and Hung MC: Curcumin
inhibits tyrosine kinase activity of p185neu and also depletes
p185neu. Clin Cancer Res. 5:1884–1891. 1999.
|
|
16
|
Huang MT, Smart RC, Wong CQ and Conney AH:
Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and
ferulic acid on tumor promotion in mouse skin by
12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:5941–5946.
1988.
|
|
17
|
Lin JK, Pan MH and Lin-Shiau SY: Recent
studies on the biofunctions and biotransformations of curcumin.
Biofactors. 13:153–158. 2000.
|
|
18
|
Choudhuri T, Pal S, Das T and Sa G:
Curcumin selectively induces apoptosis in deregulated cyclin
D1-expressed cells at G2 phase of cell cycle in a p53-dependent
manner. J Biol Chem. 280:20059–20068. 2005.
|
|
19
|
Ramachandran C and You W: Differential
sensitivity of human mammary epithelial and breast carcinoma cell
lines to curcumin. Breast Cancer Res Treat. 54:269–278. 1999.
|
|
20
|
Syng-Ai C, Kumari AL and Khar A: Effect of
curcumin on normal and tumor cells: role of glutathione and bcl-2.
Mol Cancer Ther. 3:1101–1108. 2004.
|
|
21
|
Menon LG, Kuttan R and Kuttan G:
Inhibition of lung metastasis in mice induced by B16F10 melanoma
cells by polyphenolic compounds. Cancer Lett. 95:221–225. 1995.
|
|
22
|
Menon LG, Kuttan R and Kuttan G:
Anti-metastatic activity of curcumin and catechin. Cancer Lett.
141:159–165. 1999.
|
|
23
|
Chen HW, Yu SL, Chen JJ, Li HN, Lin YC,
Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT and Yang PC:
Anti-invasive gene expression profile of curcumin in lung
adenocarcinoma based on a high throughput microarray analysis. Mol
Pharmacol. 65:99–110. 2004.
|
|
24
|
Limtrakul P, Anuchapreeda S and Buddhasukh
D: Modulation of human multidrug-resistance MDR-1 gene by natural
curcuminoids. BMC Cancer. 4:132004.
|
|
25
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983.
|
|
26
|
Savli H, Aalto Y, Nagy B, Knuutila S and
Pakkala S: Gene expression analysis of 1,25(OH)2D3-dependent
differentiation of HL-60 cells: a cDNA array study. Br J Haematol.
118:1065–1070. 2002.
|
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: a
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005.
|
|
28
|
Aggarwal BB, Kumar A and Bharti AC:
Anticancer potential of curcumin: preclinical and clinical studies.
Anticancer Res. 23:363–398. 2003.
|
|
29
|
Salomon DS, Brandt R, Ciardiello F and
Normanno N: Epidermal growth factor-related peptides and their
receptors in human malignancies. Crit Rev Oncol Hematol.
19:183–232. 1995.
|
|
30
|
Arteaga CL: Epidermal growth factor
receptor dependence in human tumors: more than just expression?
Oncologist. 7(Suppl 4): 31–39. 2002.
|
|
31
|
Richards KN, Zweidler-McKay PA, Van Roy N,
Speleman F, Trevino J, Zage PE and Hughes DP: Signaling of ERBB
receptor tyrosine kinases promotes neuroblastoma growth in vitro
and in vivo. Cancer. 116:3233–3243. 2010.
|
|
32
|
Hardy KM, Booth BW, Hendrix MJ, Salomon DS
and Strizzi L: ErbB/EGF signaling and EMT in mammary development
and breast cancer. J Mammary Gland Biol Neoplasia. 15:191–199.
2010.
|
|
33
|
Earp HS, Dawson TL, Li X and Yu H:
Heterodimerization and functional interaction between EGF receptor
family members: a new signaling paradigm with implications for
breast cancer research. Breast Cancer Res Treat. 35:115–132.
1995.
|
|
34
|
Dancey JE and Freidlin B: Targeting
epidermal growth factor receptor - are we missing the mark? Lancet.
362:62–64. 2003.
|
|
35
|
Chen A, Xu J and Johnson AC: Curcumin
inhibits human colon cancer cell growth by suppressing gene
expression of epidermal growth factor receptor through reducing the
activity of the transcription factor Egr-1. Oncogene. 25:278–287.
2006.
|
|
36
|
Shishodia S, Singh T and Chaturvedi MM:
Modulation of transcription factors by curcumin. Adv Exp Med Biol.
595:127–148. 2007.
|
|
37
|
Choi BH, Kim CG, Bae YS, Lim Y, Lee YH and
Shin SY: p21 Waf1/Cip1 expression by curcumin in U-87MG human
glioma cells: role of early growth response-1 expression. Cancer
Res. 68:1369–1377. 2008.
|
|
38
|
Chen A and Xu J: Activation of PPAR{gamma}
by curcumin inhibits Moser cell growth and mediates suppression of
gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest
Liver Physiol. 288:447–456. 2005.
|
|
39
|
Han SS, Chung ST, Robertson DA, Ranjan D
and Bondada S: Curcumin causes the growth arrest and apoptosis of B
cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa
B, and p53. Clin Immunol. 93:152–161. 1999.
|
|
40
|
Liu J, Liu YG, Huang R, Yao C, Li S, Yang
W, Yang D and Huang RP: Concurrent down-regulation of Egr-1 and
gelsolin in the majority of human breast cancer cells. Cancer
Genomics Proteomics. 4:377–385. 2007.
|
|
41
|
Parra E and Ferreira J: The effect of
siRNA-Egr-1 and camptothecin on growth and chemosensitivity of
breast cancer cell lines. Oncol Rep. 23:1159–1165. 2010.
|
